REVIEW- Dr. Richard Adrouny:
I rarely leave reviews like this, but I believe patients deserve to hear about my experience under the care of Dr. Richard Adrouny during treatment for B-cell lymphoma and Waldenström macroglobulinemia.
My chemotherapy regimen included Rituximab, Cytoxan, Doxorubicin, Prednisone, Polatuzumab (Polivy), and Fulphila injections.
Throughout treatment, I repeatedly reported serious and worsening symptoms to Dr. Adrouny's office, including persistent daily coughing, increasing weakness, progressive numbness in my feet, inflammation, and mobility problems. These symptoms continued to worsen over time.
I was directed to the emergency department multiple times, where I spent hours waiting without meaningful answers or resolution. Despite ongoing neurological symptoms, I did not feel my concerns were taken seriously or aggressively investigated.
Eventually, another physician later discontinued Polivy at Enloe Hospital. By that point, I had developed significant loss of sensation in my feet that continues today and affects my mobility and ability to drive.
Additional concerns from my experience included:
* Delayed follow-up regarding neurological symptoms
* PET imaging not initially scheduled after chemotherapy cycle #6 until I personally raised the issue
* Lack of timely coordination regarding referrals and follow-up care
* Repeated symptom reports that I felt were minimized rather than fully investigated
* Concerns regarding management of Fulphila side effects and inflammation symptoms
I also attempted to address these concerns directly through Enloe Health's administration and patient experience department. Despite multiple conversations and emails requesting assistance and transfer of care, I did not feel meaningful action was taken.
At one point, after asking questions regarding my treatment and complications, I was told I could seek care elsewhere.
I am now pursuing transfer of care to another cancer center.
Based on my experience, I strongly encourage patients to:
* Keep detailed records of symptoms and communications
* Ask specifically how chemotherapy side effects will be monitored
* Request clarification about imaging schedules and follow-up plans
* Seek second opinions early if symptoms continue worsening
This review reflects my personal experience and documented interactions during treatment. read more